Tag: COVID-19 pill

ALEXANDRIA, Va. – The National Community Pharmacists Association and other pharmacy stakeholders says the Food and Drug Administration’s decision to prevent pharmacists from prescribing a new COVID-19 antiviral medication from Pfizer wastes time and money and puts patients at risk. "Pharmacists are educated, trained, and able to assess patients in accordance with clinical guidelines for appropriate use of these more convenient COVID-19 treatment options,” say stakeholders. “The...